Boostrix 50090-1377
Generic: Tetanus Toxoid, Reduced Diphtheria Toxoid And Acellular Pertussis Vaccine, Adsorbed
Product NDC
50090-1377- Manufacturer
- A-S Medication Solutions
- Dosage Form
- Suspension
- Route
- Intramuscular
- Product Type
- Vaccine
- Marketing Start
- July 24, 2009
- Listing Expires
- December 31, 2026
- Application
- BLA125106
Active Ingredients
| Ingredient | Strength |
|---|---|
| Bordetella Pertussis Filamentous Hemagglutinin Antigen (formaldehyde Inactivated) | 8 ug/.5mL |
| Bordetella Pertussis Pertactin Antigen (formaldehyde Inactivated) | 2.5 ug/.5mL |
| Bordetella Pertussis Toxoid Antigen (formaldehyde, Glutaraldehyde Inactivated) | 8 ug/.5mL |
| Clostridium Tetani Toxoid Antigen (formaldehyde Inactivated) | 5 [iU]/.5mL |
| Corynebacterium Diphtheriae Toxoid Antigen (formaldehyde Inactivated) | 2.5 [iU]/.5mL |
Drug Class
Actively Acquired Immunity [PE]Actively Acquired Immunity [PE]Actively Acquired Immunity [PE]
Packaging Options(2)
10 SYRINGE in 1 CARTON (50090-1377-0) / .5 mL in 1 SYRINGE (50090-1377-2)
1 SYRINGE in 1 POUCH (50090-1377-1) / .5 mL in 1 SYRINGE
Related Products
All Tetanus Toxoid, Reduced Diphtheria Toxoid And Acellular Pertussis Vaccine, Adsorbed NDC codes →External Resources